ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery

SAN DIEGO: SAN DIEGO, July 21, 2021 /PRNewswire/ -- ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head of Surgery. Dr. Wilensky will be responsible for training surgeons and advancing innovative approaches for ViaCyte's pancreatic islet...

Click to view original post